Erste Asset Management Gmb H Graphite Bio, Inc. Transaction History

Erste Asset Management Gmb H

  • $8.15 Trillion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 26, 2024
SELL
$2.18 - $2.77 $25,942 - $32,963
-11,900 Closed
0 $0
Q3 2022

Nov 26, 2024
BUY
$2.82 - $4.24 $33,558 - $50,456
11,900 New
11,900 $36.5 Million
Q2 2022

Nov 26, 2024
BUY
$2.14 - $5.23 $25,466 - $62,237
11,900 New
11,900 $33.3 Million
Q1 2022

Nov 22, 2024
BUY
$5.1 - $13.06 $60,689 - $155,414
11,900 New
11,900 $61 Million

Others Institutions Holding GRPH

# of Institutions
3
Shares Held
637K
Call Options Held
0
Put Options Held
0
View Full List

About Graphite Bio, Inc.

GRPH Quotes by TradingView
  • Ticker GRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,211,200
  • Description
  • Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...
More about GRPH
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email